As everyone has heard by now, the FDA’s disastrous proposal to regulate e-cigarettes as tobacco products has gone ahead with none of the changes vaping advocates may have been hoping for. We wanted continued innovation with improved product standards; we got thinly-veiled prohibition.
Here in the states, we awoke to big news this morning from our neighbors across the pond. Today, Members of European Parliament voted on several revisions to the Tobacco Products Directive. Among them was a vote on whether or not to classify e-cigarettes as medicinal products, restricting sales to pharmacies for products with a nicotine concentration over 4%, or 4 mg/ml.
Keeping up with all of the new studies, devices, blog posts and legislation in the world of vaping isn’t easy, so we’re happy to present the first of our weekly roundups of what’s been going on in the industry: the week in vaping.
Getting caught with an e-cigarette in some schools can get you suspended, tested for drugs and lead to “possession of drug paraphernalia” being marked on your school record. This means that for some students in states such as North Carolina, New Jersey, Washington and Connecticut, you’re better off being caught with cigarettes in school than e-cigarettes.
Day 2 of the Electronic Cigarette Convention in Anaheim featured a workshop on e-cig regulations and e-liquid safety by Azim Chowdhury, Lou Ritter and Linc Williams from AEMSA.
Trump announced recently that he's backing off from the flavor ban. At least for now. While of course a welcomed move from those within the industry, it still leaves a skeptical flavor (excuse the pun) in the mouths of professionals and connoisseurs. That the battle may be won, but the war certainly isn't.
Let’s be honest, 2020 was a terrible year. Australian bush fires, the deaths of well-loved celebrities, civil unrest in the...
On November 8, California voters decided to say a firm ‘yes’ to Proposition 56, which will increase the excise tax on cigarettes and other products containing nicotine by a hefty margin.
With Christmas just around the corner, it’s a great time to pick up new vaping gear – whether as gift for someone else or just a "to me, from me" treat – and the industry has responded with a solid selection of new devices and atomizers hitting the market in November. So this month's vaping product releases roundup is particularly well-stocked with awesome new gear!
The Week in Vaping is back, with a run-down of the latest vaping and tobacco harm reduction related research, a look at recently proposed legislation, regulations and bans on vaping – increasingly frequently stretching outdoors – and some of the best blog posts from the community this week.
A recent South Jersey Times opinion piece on e-cigs illustrates this ability beautifully, as if it was designed as a template for media-based e-cig bashing. If you're a journalist looking to publish some brain-dead word-farts on the topic of e-cigs, this is the resource for you.
Big tobacco giant Lorillard saw sales of blu eCigs fall by almost 40 percent in the third quarter of 2014, likely due to the fact that vapers have long-since realized that eGo-style devices or mods are vastly superior to the cigarette-sized weaklings of the vaping industry.
The FDA has issued their first approval for an e-cigarette to be sold in the US. The approved vape is the Vuse Solo, a big tobacco-backed device and its accompanying tobacco cartridge.
TL;DR The European Commission has U-turned on its preliminary decision to classify CBD as a narcotic Since 2019, CBD has...
The US Food and Drug Administration has declared a war on vaping products some time ago now. August 8th, 2016 marked...
We’ve written a letter to FDA Commissioner Margaret Hamburg – who has already received a “protect the children” call from the Attorneys General – putting forward the case for e-cigarettes and suggesting how they should be regulated.
Skycig is set to become blu eCigs in May, after recently being acquired by Lorillard. Is this a sign Big Tobacco will take over the market?
Today the Royal Society became the site of the E-Cigarette Summit, a day dedicated to debating the safety, efficacy and regulation of e-cigarettes. The day was split into three sessions, firstly looking at the safety and efficacy, then moving on to regulation, and finally looking at the controversies surrounding the technology.
The effectiveness of electronic cigarettes as a quit smoking aid just received a huge boost with a new Italian study published on the scientific journal PLOS ONE. In the first ever clincal trial on the effectiveness of tobacco reduction and smoking cessation rates using e-cigarettes, ECLAT found up to a 13 percent quit rate in participants over a 52 week period.




















